The EBMT Clinical Outcomes Group (COG) has developed the first phase of a bespoke risk-adapted international benchmarking model for one-year survival following allogeneic and autologous HSCT based on current capabilities within the EBMT registry core dataset. In November 2020, centres received the first data-completeness reports. This webinar will explain the origins and methodology of the model, the centre perspective and the next steps. The webinar will be an opportunity for users to address questions to the expert panel and to give feedback on this first report. This feedback will be taken into account for the next phase of this project.
Kindly supported by